Piao Li

632 total citations
20 papers, 457 citations indexed

About

Piao Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Piao Li has authored 20 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Piao Li's work include Fibroblast Growth Factor Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Natural product bioactivities and synthesis (3 papers). Piao Li is often cited by papers focused on Fibroblast Growth Factor Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Natural product bioactivities and synthesis (3 papers). Piao Li collaborates with scholars based in China, United Kingdom and United States. Piao Li's co-authors include Hong Qiu, Dian Liu, Tingting Huang, Yihua Wang, Xianglin Yuan, Wei Yao, Li Sun, Huihua Xiong, Liang Zhuang and Yan Zhang and has published in prestigious journals such as The Journal of Immunology, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Piao Li

20 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Piao Li China 10 243 124 98 83 69 20 457
Katherine Chastain United States 13 273 1.1× 241 1.9× 93 0.9× 57 0.7× 86 1.2× 45 607
Sebastian Szubert Poland 14 144 0.6× 120 1.0× 75 0.8× 59 0.7× 42 0.6× 51 486
Atsushi Tanaka Japan 15 163 0.7× 95 0.8× 73 0.7× 61 0.7× 81 1.2× 42 595
Yanyan Zhu United States 10 155 0.6× 198 1.6× 37 0.4× 51 0.6× 130 1.9× 23 378
Weiqing Shao China 9 229 0.9× 152 1.2× 166 1.7× 108 1.3× 91 1.3× 20 503
Pei‐Yu Huang China 13 127 0.5× 262 2.1× 117 1.2× 55 0.7× 126 1.8× 26 529
José González Spain 10 365 1.5× 99 0.8× 76 0.8× 29 0.3× 25 0.4× 25 507
Narisorn Kongruttanachok Thailand 10 494 2.0× 86 0.7× 114 1.2× 74 0.9× 37 0.5× 20 679
Duygu Derin Türkiye 12 178 0.7× 181 1.5× 81 0.8× 60 0.7× 79 1.1× 24 424

Countries citing papers authored by Piao Li

Since Specialization
Citations

This map shows the geographic impact of Piao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piao Li more than expected).

Fields of papers citing papers by Piao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piao Li. The network helps show where Piao Li may publish in the future.

Co-authorship network of co-authors of Piao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Piao Li. A scholar is included among the top collaborators of Piao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piao Li. Piao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Piao, Yangyang Zhou, Wei Zhao, et al.. (2024). Thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of EGF to inhibit cervical cancer recurrence. Colloids and Surfaces B Biointerfaces. 236. 113795–113795. 13 indexed citations
3.
Wang, Shennan, et al.. (2023). SOX2 Promotes Radioresistance in Non-small Cell Lung Cancer by Regulating Tumor Cells Dedifferentiation. International Journal of Medical Sciences. 20(6). 781–796. 9 indexed citations
4.
Li, Yiming, Xiuyuan Zhang, Piao Li, et al.. (2023). FGFR2 upregulates PAI-1 via JAK2/STAT3 signaling to induce M2 polarization of macrophages in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(4). 166665–166665. 17 indexed citations
5.
Li, Piao, Lingling Li, Zhou Li, et al.. (2022). Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway. Cancer Cell International. 22(1). 7–7. 15 indexed citations
6.
Li, Lingling, et al.. (2022). FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial–mesenchymal transition and cell cycle arrest. Cancer Cell International. 22(1). 70–70. 16 indexed citations
7.
Zhou, Li, et al.. (2022). CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma. International Journal of General Medicine. Volume 15. 3809–3826. 5 indexed citations
8.
Huang, Shanshan, Yongbiao Huang, Wanling Lin, et al.. (2022). Sitagliptin Alleviates Radiation‐Induced Intestinal Injury by Activating NRF2‐Antioxidant Axis, Mitigating NLRP3 Inf‐‐lammasome Activation, and Reversing Gut Microbiota Disorder. Oxidative Medicine and Cellular Longevity. 2022(1). 2586305–2586305. 23 indexed citations
9.
Liu, Ning, Jintong Chen, Yinghua Zhao, et al.. (2021). Role of the IL‑33/ST2 receptor axis in ovarian cancer progression (Review). Oncology Letters. 22(1). 504–504. 4 indexed citations
10.
Li, Piao, et al.. (2021). Statistical inference for the reliability of Burr-XII distribution under improved adaptive Type-II progressive censoring. Applied Mathematical Modelling. 95. 38–52. 35 indexed citations
11.
Li, Piao, Lingling Li, Shennan Wang, et al.. (2021). Effect of antitumor therapy on cancer patients infected by SARS‐CoV‐2: A systematic review and meta‐analysis. Cancer Medicine. 10(5). 1644–1655. 5 indexed citations
12.
Li, Piao, et al.. (2019). Downregulation of microRNA‐124 prevents the development of acute liver failure through the upregulation of PIM‐3. Experimental Physiology. 105(1). 108–119. 5 indexed citations
13.
Li, Piao, Tingting Huang, Dian Liu, et al.. (2019). FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway. The Journal of Immunology. 202(10). 3065–3075. 128 indexed citations
14.
Xu, Weiling, et al.. (2019). microRNA‐138 induces cell survival and reduces WNT/β‐catenin signaling of osteoarthritis chondrocytes through NEK2. IUBMB Life. 71(9). 1355–1366. 24 indexed citations
15.
Liu, Dian, Yihua Wang, Piao Li, et al.. (2018). FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway. Cellular Physiology and Biochemistry. 50(4). 1332–1345. 33 indexed citations
16.
Huang, Tingting, Dian Liu, Piao Li, et al.. (2017). FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1. International Journal of Oncology. 50(5). 1501–1512. 107 indexed citations
19.
Li, Piao, et al.. (2015). Effects of Yoga on cancer-related fatigue in breast cancer patients: Meta-analysis. Zhonghua xiandai huli zazhi. 21(28). 3380–3386. 1 indexed citations
20.
Li, Piao. (2010). Extraction and Antioxidant Activity of Total Flavoniods from Patrinia. Food Science. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026